These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23293573)

  • 1. Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention.
    Rao CV; Janakiram NB; Mohammed A
    Curr Colorectal Cancer Rep; 2012 Dec; 8(4):316-324. PubMed ID: 23293573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.
    Cathcart MC; Lysaght J; Pidgeon GP
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):363-85. PubMed ID: 22134655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
    Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells.
    Ganesh R; Marks DJ; Sales K; Winslet MC; Seifalian AM
    World J Surg Oncol; 2012 Sep; 10():200. PubMed ID: 23013454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.
    Knab LM; Grippo PJ; Bentrem DJ
    World J Gastroenterol; 2014 Aug; 20(31):10729-39. PubMed ID: 25152576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes.
    El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA
    Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of COX and LOX by curcumin.
    Rao CV
    Adv Exp Med Biol; 2007; 595():213-26. PubMed ID: 17569213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.
    Meshram MA; Bhise UO; Makhal PN; Kaki VR
    Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosanoid signaling in carcinogenesis of colorectal cancer.
    Wang Y; Wang W; Sanidad KZ; Shih PA; Zhao X; Zhang G
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):257-267. PubMed ID: 29858741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Inhibitors against Potential Targets of Cyclooxygenase, Lipoxygenase and Leukotrienes.
    Dey R; Dey S; Samadder A; Saxena AK; Nandi S
    Comb Chem High Throughput Screen; 2022; 25(14):2341-2357. PubMed ID: 34533441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach.
    P JJ; Manju SL; Ethiraj KR; Elias G
    Eur J Pharm Sci; 2018 Aug; 121():356-381. PubMed ID: 29883727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
    Cianchi F; Cortesini C; Magnelli L; Fanti E; Papucci L; Schiavone N; Messerini L; Vannacci A; Capaccioli S; Perna F; Lulli M; Fabbroni V; Perigli G; Bechi P; Masini E
    Mol Cancer Ther; 2006 Nov; 5(11):2716-26. PubMed ID: 17121918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
    Celotti F; Durand T
    Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Mammalian 5-Lipoxygenase by Dietary Phenolics as an Anti-Inflammatory Mechanism: A Systematic Review.
    Giménez-Bastida JA; González-Sarrías A; Laparra-Llopis JM; Schneider C; Espín JC
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
    Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eicosanoid pathway in colorectal cancer: Recent updates.
    Tuncer S; Banerjee S
    World J Gastroenterol; 2015 Nov; 21(41):11748-66. PubMed ID: 26557000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer.
    Aliabadi A; Khanniri E; Mahboubi-Rabbani M; Bayanati M
    Eur J Med Chem; 2023 Dec; 261():115866. PubMed ID: 37862815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Co-regulatory Role of 5-Lipoxygenase and Cyclooxygenase-2 in the Carcinogenesis and their Promotion by Cigarette Smoking in Colons.
    Shen J; Li WX; Xiao ZG; Zhang L; Li MX; Li LF; Hu W; Lu L; Boudreau F; Cho CH
    Curr Med Chem; 2016; 23(11):1131-8. PubMed ID: 26997150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.